521 related articles for article (PubMed ID: 17191110)
1. Alkaline comet assay study with breast cancer patients: evaluation of baseline and chemotherapy-induced DNA damage in non-target cells.
Kopjar N; Milas I; Garaj-Vrhovac V; Gamulin M
Clin Exp Med; 2006 Dec; 6(4):177-90. PubMed ID: 17191110
[TBL] [Abstract][Full Text] [Related]
2. DNA damage in peripheral blood lymphocytes in patients during combined chemotherapy for breast cancer.
Sánchez-Suárez P; Ostrosky-Wegman P; Gallegos-Hernández F; Peñarroja-Flores R; Toledo-García J; Bravo JL; Del Castillo ER; Benítez-Bribiesca L
Mutat Res; 2008 Apr; 640(1-2):8-15. PubMed ID: 18207203
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of DNA damage in radiotherapy-treated cancer patients using the alkaline comet assay.
Gamulin M; Garaj-Vrhovac V; Kopjar N
Coll Antropol; 2007 Sep; 31(3):837-45. PubMed ID: 18041397
[TBL] [Abstract][Full Text] [Related]
4. Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictive factor.
Uriol E; Sierra M; Comendador MA; Fra J; Martínez-Camblor P; Lacave AJ; Sierra LM
Mutagenesis; 2013 Jan; 28(1):39-48. PubMed ID: 22987025
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.
Jaremko M; Justenhoven C; Schroth W; Abraham BK; Fritz P; Vollmert C; Illig T; Simon W; Schwab M; Brauch H
Pharmacogenet Genomics; 2007 Jul; 17(7):529-38. PubMed ID: 17558308
[TBL] [Abstract][Full Text] [Related]
6. Radiation sensitivity of leukocytes from healthy individuals and breast cancer patients as measured by the alkaline and neutral comet assay.
Shahidi M; Mozdarani H; Bryant PE
Cancer Lett; 2007 Nov; 257(2):263-73. PubMed ID: 17881118
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic outcomes of adjuvant chemotherapy in non-target cells of breast cancer patients.
Kopjar N; Milas I; Garaj-Vrhovac V; Gamulin M
Hum Exp Toxicol; 2007 May; 26(5):391-9. PubMed ID: 17623763
[TBL] [Abstract][Full Text] [Related]
8. [Medical treatment of early breast cancer: chemotherapy].
Ejlertsen B; Kamby C
Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
[TBL] [Abstract][Full Text] [Related]
9. Assessment of DNA sensitivity in peripheral blood leukocytes after occupational exposure to microwave radiation: the alkaline comet assay and chromatid breakage assay.
Garaj-Vrhovac V; Orescanin V
Cell Biol Toxicol; 2009 Feb; 25(1):33-43. PubMed ID: 18214694
[TBL] [Abstract][Full Text] [Related]
10. Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.
Hurria A; Brogan K; Panageas KS; Pearce C; Norton L; Jakubowski A; Zauderer M; Howard J; Hudis C
Breast Cancer Res Treat; 2005 Jul; 92(2):151-6. PubMed ID: 15986124
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of DNA damage in white blood cells of healthy human volunteers using the alkaline comet assay and the chromosome aberration test.
Kopjar N; Zeljezić D; Garaj-Vrhovac V
Acta Biochim Pol; 2006; 53(2):321-36. PubMed ID: 16582984
[TBL] [Abstract][Full Text] [Related]
12. Genotoxicity of environmental agents assessed by the alkaline comet assay.
Møller P
Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009
[TBL] [Abstract][Full Text] [Related]
13. Effect of vitamins C and E on antioxidant status of breast-cancer patients undergoing chemotherapy.
Suhail N; Bilal N; Khan HY; Hasan S; Sharma S; Khan F; Mansoor T; Banu N
J Clin Pharm Ther; 2012 Feb; 37(1):22-6. PubMed ID: 21204889
[TBL] [Abstract][Full Text] [Related]
14. Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer.
Schrohl AS; Meijer-van Gelder ME; Holten-Andersen MN; Christensen IJ; Look MP; Mouridsen HT; Brünner N; Foekens JA
Clin Cancer Res; 2006 Dec; 12(23):7054-8. PubMed ID: 17114213
[TBL] [Abstract][Full Text] [Related]
15. [Results of a study on fatigue in breast cancer patients receiving adjuvant chemotherapy: the first four days after treatment are the worst].
de Jong N; Kester AD; Schouten HC; Abu-Saad HH; Courtens AM
Pflege Z; 2007 Nov; 60(11):620-5. PubMed ID: 18062627
[TBL] [Abstract][Full Text] [Related]
16. DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals.
Sigurdson AJ; Hauptmann M; Alexander BH; Doody MM; Thomas CB; Struewing JP; Jones IM
Mutat Res; 2005 Oct; 586(2):173-88. PubMed ID: 16099702
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of toxicities induced by chemotherapy in breast cancer patients.
Mehreen L; Khanam A
Biomed Pharmacother; 2005 Oct; 59(9):524-7. PubMed ID: 16154313
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced DNA damage and repair in peripheral blood mononuclear cells from Nijmegen breakage syndrome patients and carriers assessed by the Comet assay.
Bürger S; Schindler D; Fehn M; Mühl B; Mahrhofer H; Flentje M; Hoehn H; Seemanová E; Djuzenova CS
Environ Mol Mutagen; 2006 May; 47(4):260-70. PubMed ID: 16470524
[TBL] [Abstract][Full Text] [Related]
19. Preliminary evaluation of DNA damage related with the smoking habit measured by the comet assay in whole blood cells.
Ellahueñe MF; Pérez-Alzola LP; Farfán-Urzua M; González-Hormazabal P; Garay M; Olmedo MI; Last JA
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1223-9. PubMed ID: 15247134
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
Ejlertsen B; Mouridsen HT; Jensen MB
Acta Oncol; 2008; 47(4):662-71. PubMed ID: 18465334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
